Fertility Services Market Size & Growth Forecast 2026–2035, By Segments (Provider, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Fertility Services Market size was more than USD 47.75 Billion in 2025 and is set to grow at a 7.6% CAGR between 2026 and 2035, attaining USD 99.33 Billion by 2035. The industry revenue for 2026 is estimated at USD 50.93 billion.
Get more details on this report
Request Free Sample ReportFertility Services Market Intelligence Snapshot
Regional Market Dynamics
- Europe held a 37.88% market share in 2025, supported by mature fertility clinic networks, broad ART availability, and strong clinical expertise that sustain high treatment volumes and consistent patient access.
- Asia Pacific is projected to grow at an 8.59% CAGR, fueled by expanding fertility clinic capacity, broader treatment access, rising patient acceptance of assisted conception, and continued investment in modern reproductive care.
Segment Momentum
- Fertility clinics accounted for 76.02% of the market in 2025 by offering specialized reproductive care, integrated diagnostics, treatment planning, and coordinated fertility procedures under one care pathway.
- Preservation is the fastest-growing type segment as more individuals proactively seek fertility services before age-related decline, medical treatments, or delayed family planning.
Market Expansion Drivers
- Rising global infertility rates driven by delayed pregnancies and lifestyle-related factors.
- Increasing adoption of assisted reproductive technologies expanding access to fertility treatment.
- Growth of specialized fertility clinics improving access and success rates of ART procedures.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent companies in the fertility services market include Mayo Clinic (United States), Cleveland Clinic (United States), Monash IVF Group Limited (Australia), Virtus Health Limited (Australia), CARE Fertility Group (United Kingdom), Aspire Fertility (United States), Dallas IVF (United States), Apricity Fertility UK Limited (United Kingdom), King's Fertility Limited (United Kingdom), Prelude Fertility, Inc. (United States).Regional and Segment Outlook
EuropeMarket Growth Drivers and Industry Trends
As more individuals and couples postpone parenthood into later reproductive years, the fertility services market is seeing stronger patient inflow tied to age-related declines in egg quality, reduced ovarian reserve, and a higher incidence of conception difficulties. This is reinforced by lifestyle-related factors such as stress, obesity, smoking, and metabolic disorders, which are increasing the need for clinical fertility evaluation and treatment rather than expectant management. In practice, these patterns are driving demand for the market through higher volumes of diagnostic testing, ovulation support, intrauterine insemination, and in vitro fertilization, while also shifting fertility care from a niche offering toward a more routine component of reproductive healthcare planning.
Increasing adoption of assisted reproductive technologies expanding access to fertility treatment
Broader acceptance of assisted reproductive technologies is influencing market adoption by moving fertility treatment into earlier stages of the patient journey, rather than reserving ART only for severe or long-standing infertility cases. In the fertility services market, this change is visible in rising willingness among patients and referring physicians to use IVF, ICSI, egg freezing, and related procedures as structured treatment pathways supported by better clinical awareness, improved protocols, and expanding social acceptance. As access barriers gradually ease through more provider availability and better treatment familiarity, ART is contributing to market size growth by converting previously underserved or hesitant patient groups into active users of fertility services.
Growth of specialized fertility clinics improving access and success rates of ART procedures
The expansion of dedicated fertility centers is supporting market development by making treatment more accessible, standardized, and clinically focused than in general gynecology settings. Specialized providers in the fertility services market typically concentrate expertise, laboratory infrastructure, embryology capabilities, and cycle management under one care model, which improves patient throughput and supports better execution of ART procedures. That combination tends to increase market penetration by reducing travel and referral friction, while stronger treatment outcomes and more predictable care pathways encourage patients to proceed with advanced fertility interventions earlier in the decision process.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global infertility rates driven by delayed pregnancies and lifestyle-related factors | 2.00% | High | Europe, North America | High | Near Term |
| Increasing adoption of assisted reproductive technologies expanding access to fertility treatment | 1.80% | High | Europe | High | Mid Term |
| Growth of specialized fertility clinics improving access and success rates of ART procedures | 1.60% | Moderate | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Europe held a 37.88% share of the fertility services market in 2025, backed by a well-established network of fertility clinics, broad availability of assisted reproductive technologies, and strong clinical expertise across major countries. The region’s leadership is aided by mature treatment infrastructure and consistent patient access to specialized reproductive care, which keeps procedure volumes high across IVF, diagnostic testing, and related interventions. Established provider ecosystems also help standardize service delivery and expand treatment options, sustaining steady market activity in everyday clinical practice.
Asia Pacific is projected to expand at an 8.59% CAGR over the forecast period, with the fertility services market gaining momentum as access to reproductive treatment broadens across densely populated countries and private fertility care capacity continues to scale. Growth is being fueled by rising patient willingness to pursue assisted conception, increasing clinic penetration in urban centers, and ongoing expansion of modern fertility treatment offerings. In practice, this means more patients are entering formal treatment pathways as service availability improves and providers invest in larger, more accessible care networks.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Regulated Clinical PracticeGermany's fertility services market operates within a structured regulatory environment that emphasizes quality clinical care and patient safety. Fertility centers in Germany prioritize evidence-based treatments, laboratory excellence, and multidisciplinary reproductive health services.
France 🇫🇷
Integrated Reproductive ServicesFrance emphasizes coordinated fertility care through specialized reproductive health centers and established clinical protocols. Providers in France continue enhancing access to assisted reproductive procedures while maintaining strong standards for treatment quality and patient care.
Italy 🇮🇹
Specialist Clinic ExpansionItaly continues expanding fertility services through specialized clinics offering comprehensive reproductive treatment options. Fertility providers in Italy focus on individualized patient management, laboratory capabilities, and improved access to advanced assisted reproduction techniques.
Japan 🇯🇵
Family Planning SupportJapan continues strengthening fertility services in response to changing demographic trends and delayed parenthood. Clinics across Japan increasingly focus on advanced reproductive technologies, fertility preservation, and patient-centered treatment pathways.
South Korea 🇰🇷
Technology-Enabled Fertility CareSouth Korea combines advanced reproductive medicine with modern clinical infrastructure to support fertility treatment demand. Healthcare providers in South Korea invest in laboratory innovation, embryo management technologies, and comprehensive reproductive counseling services.
United States 🇺🇸
Advanced Reproductive CareThe U.S. fertility services market benefits from broad availability of assisted reproductive technologies and specialized fertility clinics. Providers in the U.S. continue expanding personalized treatment plans, genetic screening services, and digital patient engagement to improve clinical outcomes and patient experience.
Segment Leadership and Growth Trends
Fertility Services Market Share (%), Provider, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportFertility clinics held a 76.02% share of the fertility services market in 2025, reflecting their central role in delivering specialized reproductive care while also sustaining the strongest growth momentum within the provider segment. Their leadership is grounded in the concentration of core fertility procedures, diagnostic workflows, and treatment planning within dedicated clinical settings where patients can access coordinated services under one care pathway. The same operating model is also supporting continued expansion in the fertility services market, as rising demand tends to flow toward providers with established procedural capability, clinical specialization, and the infrastructure required to manage increasingly complex and time-sensitive fertility needs.
Type Segment Analysis: Treatment (Largest Segment) vs Preservation (Fastest-Growing Segment)
Treatment accounted for a 63.37% share of the fertility services market in 2025, making it the leading type segment because it addresses the immediate objective of conception for a large portion of patients entering the care pathway. Its leadership is maintained through the fact that most clinical engagement in the fertility services market is centered on active interventions, where patients typically seek direct medical solutions for infertility rather than longer-term elective options. This keeps treatment volumes anchored to present clinical need and ongoing patient demand for outcome-focused care.
Preservation is emerging as the fastest-growing type segment in the fertility services market as reproductive planning becomes more time-sensitive and proactive rather than purely treatment-driven. Growth is being supported by increasing use of fertility services before anticipated age-related decline, medical procedures, or delayed family planning, which gives preservation stronger momentum relative to conventional alternatives tied mainly to existing infertility cases. That forward-looking use case is expanding the addressable patient base and pushing preservation adoption faster than other service types.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Provider | Fertility Clinics, Hospitals and Others | Fertility Clinics | Fertility Clinics |
| Type | Diagnosis, Treatment, Preservation | Treatment | Preservation |
Competitive Landscape and Market Positioning
1. Mayo Clinic (United States)
2. Cleveland Clinic (United States)
3. Monash IVF Group Limited (Australia)
4. Virtus Health Limited (Australia)
5. CARE Fertility Group (United Kingdom)
6. Aspire Fertility (United States)
7. Dallas IVF (United States)
8. Apricity Fertility UK Limited (United Kingdom)
9. King's Fertility Limited (United Kingdom)
10. Prelude Fertility Inc. (United States)
The fertility services market is expanding due to increasing adoption of personalized reproductive treatment approaches. Innovation is centered on improving success rates through advanced genetic and embryology techniques. The fertility services market is also influenced by growing demand for integrated reproductive health solutions. Continuous advancement in laboratory technologies is improving treatment precision.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Future Family | Sep-25 | Future Family secured a $400 million financing program from Clear Haven Capital Management to scale its fertility lending platform. This capital enables broader patient access to IVF and egg-freezing financing, supporting the growth of its nationwide fertility insurance and patient financing ecosystem to meet increasing consumer demand for assisted reproductive services. |
| Ontario Government | Oct-25 | The Ontario government launched a $250 million investment initiative to expand the Ontario Fertility Program. This funding aims to scale capacity across both hospital and community-based IVF providers, directly reducing wait times and improving equitable access to publicly funded reproductive healthcare services throughout the province. |
| NewGenIvf Group Limited | Aug-25 | NewGenIvf Group Limited completed its SPAC merger with A SPAC I Acquisition and listed on the Nasdaq. The transaction provides the company with significant growth capital to accelerate the expansion of its fertility services platform across Asia and international markets, strengthening its competitive positioning in the global reproductive healthcare sector. |
| CHA Healthcare | Aug-25 | CHA Healthcare acquired a controlling stake in Singapore Medical Group, integrating its multi-specialty network into a regional healthcare platform. This strategic consolidation expands CHA’s fertility and specialized medical service footprint across Southeast Asia, facilitating cross-border growth and enhancing service delivery capabilities in the region’s private healthcare market. |
| Indira IVF | Sep-25 | Indira IVF acquired a stake in Banker IVF, strengthening its clinical presence in Gujarat. By combining its national operational scale with Banker IVF's regional network, the company aims to enhance IVF accessibility in key urban centers and optimize service delivery infrastructure across underserved Indian fertility markets. |
| FertGroup | Aug-25 | FertGroup partnered with Future Fertility to implement AI-driven oocyte assessment software across its Brazilian clinic network. This integration of digital analytical tools enhances embryo and egg evaluation capabilities, supporting improved clinical decision-making and standardizing high-tech diagnostic outcomes across the provider’s regional facilities. |
| Blue Cross Blue Shield | Sep-25 | Blue Cross Blue Shield Global Solutions partnered with Carrot to launch a global fertility and family-building benefits program for expatriate employees. This integration incorporates IVF and reproductive health services into international insurance offerings, marking a strategic expansion of employer-sponsored fertility benefits to support mobile workforces on a global scale. |
| HCA Healthcare UK | Oct-25 | HCA Healthcare UK expanded its fertility services network by opening a dedicated satellite clinic at its Canary Wharf Outpatients Centre in London. The facility increases the provider's outpatient capacity, addressing high regional demand for assisted reproductive care through an integrated diagnostic and primary care service model. |
| Cryoport, Inc. | Apr-23 | Cryoport, Inc. entered a three-year supply chain agreement with Boston IVF to standardize the logistics and transportation of sensitive reproductive materials across the U.S. This partnership addresses critical infrastructure needs in the fertility market, focusing on the secure, temperature-controlled transit of biological assets to maintain clinical viability during storage and transport. |
| Zora Health | Jul-25 | Zora Health secured $1 million in seed funding to launch a digital fertility care platform. The investment is earmarked for building an integrated reproductive health coordination tool, which streamlines access to IVF, egg freezing, and fertility testing services through a tech-enabled interface designed to improve patient navigation and care efficiency. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Fertility Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Fertility Services Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of fertility services?
What is the forecasted size of the fertility services industry?
How are delayed pregnancies and lifestyle-related factors influencing demand patterns in the fertility services market?
How is the expansion of assisted reproductive technologies and fertility clinics changing access and adoption in the fertility services market?
Why are fertility clinics the leading providers in the fertility services market?
Which type segment is growing the fastest in the fertility services market?
Why does Europe lead the fertility services market?
What is driving fertility services market growth in Asia Pacific?
Which companies dominate the fertility services landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization